U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

PROPYPERONE

MORE DETAILS

  HG22108KQK

Status:
Possibly Marketed Outside US
Source:
21 CFR 355
(2018)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=65b9b2f3-aefe-dcc9-e053-2a91aa0a8242
First approved in 2018
Source:
21 CFR 355
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=65b9b2f3-aefe-dcc9-e053-2a91aa0a8242
Class (Stereo):
CHEMICAL (ACHIRAL)
Propyperone is acylpiperidine derivative patented by N. V. Research Laboratorium as a neuroleptic agent with mammotropic activity.
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966